Ventures Vii (parallel) Lp Cmea is 10% at Auspex Pharmaceuticals, Inc. (ASPX). They have made 9 open-market trades across 2 companies since 2014, most recently 2015-02-13.
CIK 0001405972
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.3M since 2014, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASPX | SELL | 2015-02-12 | 2015-02-17 | $63.08 | $7.7M | N/A | N/A | N/A |
| ASPX | SELL | 2015-02-10 | 2015-02-17 | $61.34 | $4.5M | N/A | N/A | N/A |
| ASPX | SELL | 2015-02-04 | 2015-02-06 | $59.39 | $5.5M | N/A | N/A | N/A |
| ARDX | SELL | 2015-01-30 | 2015-02-03 | $27.37 | $4.7M | -44.0% | -2.0% | -2.0% |
| ARDX | SELL | 2015-01-08 | 2015-01-12 | $24.25 | $7.3M | -44.0% | -2.0% | -2.0% |
| ASPX | SELL | 2015-01-08 | 2015-02-17 | $49.13 | $164K | N/A | N/A | N/A |
| ASPX | SELL | 2014-12-18 | 2014-12-22 | $50.14 | $9.8M | N/A | N/A | N/A |
| ASPX | SELL | 2014-08-25 | 2014-08-27 | $20.81 | $112K | N/A | N/A | N/A |
| ASPX | BUY | 2014-02-10 | 2014-02-12 | $12.00 | $1.3M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.